Material Safety Data Sheets
Please note that this document contains a complete set of MSDS
documents assembled for your convenience.
If you have any questions please contact Technical Support
1.800.251.5115
techservice@immunoconcepts.com
www.immunoconcepts.com
Immuno Concepts, N.A. Ltd.
9779-D Business Park Drive
Sacramento, CA 95827 USA
Telephone: 916-363-2649
October 31, 2003
MATERIAL SAFETY DATA SHEET (MSDS)
- - - - - PRODUCT IDENTIFICATION - - - - -
NAME: RELISA?TEST SYSTEMS
CATALOG #: 7096-01, 7096-02, 7096-03, 7096-05, 7096-09, 7096-10, 7096-11, 7096-13, 7096-15, 7096-16, 7096-17,
7696-01, 7696-02, 7696-09, 7696-10, 7696-11, CUSTOM RELISA?TEST SYSTEMS CATALOG SERIES
8000-8999.
- - - - - COMPOSITION/INFORMATION ON INGREDIENTS - - - - - -
THIS PRODUCT CONTAINS HUMAN SOURCE MATERIAL. ALL HUMAN SOURCE MATERIALS USED FOR THIS
PRODUCT HAVE BEEN TESTED AND FOUND TO BE NEGATIVE (NOT REPEATEDLY REACTIVE) FOR ANTIBODIES TO
HUMAN IMMUNODEFICIENCY VIRUS-1 (HIV-1), HUMAN IMMUNODEFICIENCY VIRUS-2 (HIV-2), HEPATITIS C VIRUS
(HCV) AND FOR HEPATITIS B SURFACE ANTIGEN (HBsAG) BY FDA APPROVED METHODS. NO TEST METHOD CAN
OFFER COMPLETE ASSURANCE THAT HIV-1, HIV-2, HCV, HBV OR OTHER INFECTIOUS AGENTS ARE ABSENT. ALL
KIT MATERIALS SHOULD BE HANDLED IN THE SAME MANNER AS POTENTIALLY INFECTIOUS MATERIALS.
- - - - - CHEMICAL HAZARDS IDENTIFICATION - - - - -
CHEMICAL SUBSTANCES PRESENT IN THIS PRODUCT, BUT NOT INCLUDED IN THIS MSDS DO NOT MEET THE
HAZARDOUS SUBSTANCE CRITERIA IN EUROPEAN COMMUNITY COUNCIL DIRECTIVE 88/379/EEC OR OSHA
HAZARD COMMUNICATION STANDARD 29 CFR 1910.1200 OR ARE PRESENT IN CONCENTRATIONS WHICH ARE
BELOW THAT REQUIRED FOR THE PREPARATION OF AN MSDS.
THIS MSDS CONTAINS THE FOLLOWING DOCUMENTS:
4.14.01.007.008 MSDS FOR RELISA?TEST SYSTEMS
4.14.01.007.010 MSDS FOR PRODUCTS CONTAINING SODIUM AZIDE
4.14.01.007.011 MSDS FOR RELISA?SUBSTRATE SOLUTION
4.14.01.007.012 MSDS FOR RELISA?STOPPING SOLUTION
4.14.01.007.013 MSDS FOR PRODUCTS CONTAINING MATERIALS OF ANIMAL ORIGIN
- - - - - OTHER INFORMATION - - - - -
THE ABOVE INFORMATION IS BELIEVED TO BE CORRECT BUT DOES NOT PURPORT TO BE ALL-INCLUSIVE AND
SHALL BE USED ONLY AS A GUIDE. IMMUNO CONCEPTS, N.A. LTD. SHALL NOT BE HELD LIABLE FOR ANY DAMAGE
RESULTING FROM HANDLING OR CONTACT WITH THE ABOVE PRODUCT.
COPYRIGHT 2001 IMMUNO CONCEPTS, N.A. LTD.
LICENSE GRANTED TO MAKE UNLIMITED PAPER COPIES FOR INTERNAL USE ONLY.
FICHE SIGNAL蒚IQUE DE S蒀URIT?(MSDS)
- - - - - IDENTIFICATION DU PRODUIT - - - - -
NOM: SYST萂ES DE TEST RELISA?br>
R蒄. CATALOGUE: 7096-01, 7096-02, 7096-03, 7096-05, 7096-09, 7096-10, 7096-11, 7096-13, 7096-15, 7096-16, 7096-
17, 7696-01, 7696-02, 7696-09, 7696-10, 7696-11, CATALOGUE DES SYST萂ES DE TEST RELISA?br>
PERSONNALIS蒘, S蒖IE 8000-8999.
- - - - - COMPOSITION/INFORMATIONS RELATIVES AUX INGR蒁IENTS - - - - - -
CE PRODUIT CONTIENT DES MAT蒖IELS D!ORIGINE HUMAINE. TOUS LES MAT蒖IELS D!ORIGINE HUMAINE
UTILIS蒘 DANS LA COMPOSITION DE CE PRODUIT ONT 蒚?TEST蒘 ET SE SONT R蒝蒐蒘 N蒅ATIFS (NON-
R葾CTIVIT?R蒔蒚蒃) VIS-?VIS DES ANTICORPS DES VIRUS DE L!IMMUNOD蒄ICIENCE HUMAINE 1 ET 2 (VIH 1 ET
2), DE L'ANTICORPS DU VIRUS DE L!H蒔ATITE C (HCV) ET DE L!ANTIG萅E DE SURFACE DE L!H蒔ATITE B (HBsAg),
Document ID # 4.14.01.007.008 Revision # 3.0 Issue Date: 10/31/03 Page 1 of 5
Immuno Concepts, N.A. Ltd.
9779-D Business Park Drive
Sacramento, CA 95827 USA
Telephone: 916-363-2649
November 17, 2005
MATERIAL SAFETY DATA SHEET (MSDS)
SECTION 1. - - - - - - - - - PRODUCT IDENTIFICATION- - - - - - - - - -
NAME AND
CATALOG #: FLUORESCENT ANCA TEST SYSTEM CONJUGATES, CONTROLS AND DILUENTS - CATALOG NUMBER
SERIES: 10009, 10075, 10021, 10026, 10031, 10100.
FLUORESCENT ANA, ANA-Ro and IgG ANA-Ro TEST SYSTEM CONJUGATES AND CONTROLS
CATALOG NUMBER SERIES: 2009, 2009-Ro, 2009G-Ro, 2075, 2075-Ro, 2075G-Ro, 2021, 2022, 2023, 2024,
2025, 2026, 2027, 2028, 2029, 2031, 2032, 2033, 2035, 2035-Ro, 2036, 2037, 2038, 2039, 2041.
FLUORESCENT nDNA TEST SYSTEMS CONJUGATES AND CONTROLS CATALOG NUMBER SERIES:
3009, 3009G, 3075, 3075G, 3021, 3026, 3031.
FLUORESENT EBV-VCA, EBNA AND EA TEST SYSTEMS CONJUGATES AND CONTROLS CATALOG
NUMBER SERIES: 9009, 9075, 9021, 9026, 9031.
AUTO ID?AUTOANTIBODY TEST SYSTEMS PLATES AND REAGENTS CATALOG NUMBER SERIES:
7010, 6001, 6002, 6003, 6004, 6005, 6050, 6051, 7001, 7002, 7003.
RELISA?CONTROLS AND CALIBRATORS CATALOG NUMBER SERIES: 7021, 7022, 7026, 7031, 7261,
7262, 7263, 7264, 7265
UNIVERSAL MOUNTING MEDIUM CATALOG NUMBER SERIES: 1111
UNIVERSAL COUNTERSTAIN (0.5% EVAN!S BLUE) CATALOG NUMBER SERIES: 1105
SERUM DILUENT CATALOG NUMBER SERIES: 100, 200, 500, 1000.
PSITS PATIENT SAMPLE CATALOG NUMBER: 1800.
FITC MICROBEAD QC SLIDE CATALOG NUMBER: 1900.
HAZARD: SODIUM AZIDE (0.1%) USED AS A PRESERVATIVE. THE FULL MSDS ON SODIUM AZIDE (NaN3) IS
GIVEN BELOW.
SECTION 2. - - - - - COMPOSITION/INFORMATION ON INGREDIENTS - - - - - -
CAS #: 26628-22-8
MF: NaN3
EC NO: 247-852-1
SYNONYMS: AZIDE, SODIUM * AZOTURE DE SODIUM (FRENCH) * AZYDEK SODU (POLISH) * KAZOE * NATRIUMAZID
(GERMAN) * NATRIUMMAZIDE (DUTCH) * NCI-C06462 * NEMAZYD * NSC 3072 * RCRA WASTE NUMBER P105 * SMITE *
SODIUM AZIDE (ACGIH) * SODIUM, AZOTURE DE (FRENCH) * SODIUM, AZOTURO DI (ITALIAN) * U-3886 *
SECTION 3. - - - - - - - - - - HAZARDS IDENTIFICATION - - - - - - - - -
LABEL PRECAUTIONARY STATEMENTS
? HIGHLY TOXIC (USA)
? VERY TOXIC (EU)
? MAY CAUSE HERITABLE GENETIC DAMAGE.
? VERY TOXIC BY INHALATION, IN CONTACT WITH SKIN AND IF SWALLOWED.
? CONTACT WITH ACIDS LIBERATES VERY TOXIC GAS.
? HEATING MAY CAUSE AN EXPLOSION.
? READILY ABSORBED THROUGH SKIN.
? TARGET ORGAN(S): NERVES, HEART
? IN CASE OF ACCIDENT OR IF YOU FEEL UNWELL, SEEK MEDICAL ADVICE IMMEDIATELY (SHOW THE LABEL
WHERE POSSIBLE).
? WEAR SUITABLE PROTECTIVE CLOTHING, GLOVES AND EYE/FACE PROTECTION.
? DO NOT BREATHE DUST.
Document ID # 4.14.01.007.010 Revision # 2.0 Issue Date: 11/17/05 Page 1 of 28
SECTION 4. - - - - - - - - - - FIRST-AID MEASURES- - - - - - - - - - -
? IF SWALLOWED, WASH OUT MOUTH WITH WATER PROVIDED PERSON IS CONSCIOUS.
? CALL A PHYSICIAN IMMEDIATELY.
? IF INHALED, REMOVE TO FRESH AIR. IF NOT BREATHING GIVE ARTIFICIAL RESPIRATION. IF BREATHING IS
DIFFICULT, GIVE OXYGEN.
? IN CASE OF SKIN CONTACT, FLUSH WITH COPIOUS AMOUNTS OF WATER FOR AT LEAST 15 MINUTES. REMOVE
CONTAMINATED CLOTHING AND SHOES. CALL A PHYSICIAN.
? IN CASE OF CONTACT WITH EYES, FLUSH WITH COPIOUS AMOUNTS OF WATER FOR AT LEAST 15 MINUTES.
ASSURE ADEQUATE FLUSHING BY SEPARATING THE EYELIDS WITH FINGERS. CALL A PHYSICIAN.
SECTION 5. - - - - - - - - - FIRE FIGHTING MEASURES - - - - - - - - - -
EXTINGUISHING MEDIA
? DRY CHEMICAL POWDER.
? DO NOT USE WATER.
SPECIAL FIREFIGHTING PROCEDURES
? WEAR SELF-CONTAINED BREATHING APPARATUS AND PROTECTIVE CLOTHING TO PREVENT CONTACT WITH
SKIN AND EYES.
UNUSUAL FIRE AND EXPLOSIONS HAZARDS
? EMITS TOXIC FUMES UNDER FIRE CONDITIONS.
? CONTAINER EXPLOSION MAY OCCUR UNDER FIRE CONDITIONS.
SECTION 6. - - - - - - - - ACCIDENTAL RELEASE MEASURES- - - - - - - - -
? WEAR SELF-CONTAINED BREATHING APPARATUS, RUBBER BOOTS AND HEAVY
? RUBBER GLOVES.
? SWEEP UP, PLACE IN A BAG AND HOLD FOR WASTE DISPOSAL.
? AVOID RAISING DUST.
? VENTILATE AREA AND WASH SPILL SITE AFTER MATERIAL PICKUP IS COMPLETE.
? EVACUATE AREA.
SECTION 7. - - - - - - - - - - HANDLING AND STORAGE- - - - - - - - - - -
REFER TO SECTION 8.
SECTION 8. - - - - - - EXPOSURE CONTROLS/PERSONAL PROTECTION- - - - - -
? SAFETY SHOWER AND EYE BATH.
? USE ONLY IN A CHEMICAL FUME HOOD.
? WASH CONTAMINATED CLOTHING BEFORE REUSE.
? WASH THOROUGHLY AFTER HANDLING.
? DO NOT BREATHE DUST.
? DO NOT GET IN EYES, ON SKIN, ON CLOTHING.
? AVOID PROLONGED OR REPEATED EXPOSURE.
? NIOSH/MSHA-APPROVED RESPIRATOR.
? COMPATIBLE CHEMICAL-RESISTANT GLOVES.
? CHEMICAL SAFETY GOGGLES.
? KEEP TIGHTLY CLOSED.
? STORE IN A COOL DRY PLACE.
? EXPLODES WHEN HEATED.
? AZIDE REACTS WITH MANY HEAVY METALS SUCH AS LEAD, COPPER, MERCURY, SILVER, GOLD TO FORM
EXPLOSIVE COMPOUNDS. COPPER AND LEAD AZIDES ARE MORE SENSITIVE THAN NITROGLYCERINE. AZIDE
REACTS WITH METAL HALIDES TO GIVE A RANGE OF METAL AZIDE HALIDES, MANY OF WHICH ARE EXPLOSIVE.
? INCOMPATIBLE WITH CHROMYL CHLORIDE, HYDRAZINE, BROMINE, CARBON DISULFIDE, DIMETHYL SULFATE,
DIBROMOMALONITRILE.
? HEAT-SENSITIVE.
SECTION 9. - - - - - - - PHYSICAL AND CHEMICAL PROPERTIES - - - - - - -
PHYSICAL PROPERTIES
SOLUBILITY:
? WATER -Z26130
Document ID # 4.14.01.007.010 Revision # 2.0 Issue Date: 11/17/05 Page 2 of 28
? SPECIFIC GRAVITY: 1.85
? PH: 10.0
SECTION 10. - - - - - - - - -STABILITY AND REACTIVITY - - - - - - - - -
STABILITY
? STABLE.
INCOMPATIBILITIES
? HALOGENATED SOLVENTS
? AVOID CONTACT WITH METALS.
? AVOID CONTACT WITH ACID.
? ACID CHLORIDES
HAZARDOUS COMBUSTION OR DECOMPOSITION PRODUCTS
? NITROGEN OXIDES
HAZARDOUS POLYMERIZATION
? WILL NOT OCCUR.
SECTION 11. - - - - - - - - - TOXICOLOGICAL INFORMATION - - - - - - - -
ACUTE EFFECTS
? MAY CAUSE SKIN IRRITATION.
? MAY BE FATAL IF ABSORBED THROUGH SKIN.
? MAY CAUSE EYE IRRITATION.
? MAY BE FATAL IF INHALED.
? MATERIAL MAY BE IRRITATING TO MUCOUS MEMBRANES AND UPPER RESPIRATORY TRACT.
? MAY BE FATAL IF SWALLOWED.
? EXPOSURE CAN CAUSE: NAUSEA, HEADACHE AND VOMITING
? LABORATORY EXPERIMENTS IN ANIMALS HAVE SHOWN SODIUM AZIDE TO PRODUCE A PROFOUND
HYPOTENSIVE EFFECT, DEMYELINATION OF MYELINATED NERVE FIBERS IN THE CENTRAL NERVOUS SYSTEM,
TESTICULAR DAMAGE, BLINDNESS, ATTACKS OF RIGIDITY, HEPATIC AND CEREBRAL EFFECTS.
CHRONIC EFFECTS
TARGET ORGAN(S):
? NERVES, HEART
? BRAIN
? MAY ALTER GENETIC MATERIAL.
RTECS #: VY8050000
? SODIUM AZIDE
TOXICITY DATA
? ORL-WMN LDLO:786 MG/KG MTAEEB 4,219,1989
? ORL-MAN LDLO:29 MG/KG MTAEEB 4,219,1989
? ORL-MAN LDLO:129 MG/KG JATOD3 20,134,1996
? ORL-WMN LDLO:14 MG/KG JFSCAS 35,193,1990
? ORL-MAN LDLO:143 MG/KG JTCTDW 24,339,1986
? ORL-RAT LD50:27 MG/KG FMCHA2 -,C32,1991
? IHL-RAT LC50:37 MG/M3 STGNBT -,173,1999
? SKN-RAT LD50:50 MG/KG STGNBT -,173,1999
? SCU-RAT LD50:45100 UG/KG MEPAAX 12,427,1961
? ITR-RAT LD50:47500 UG/KG MEPAAX 12,427,1961
Document ID # 4.14.01.007.010 Revision # 2.0 Issue Date: 11/17/05 Page 3 of 28
? ORL-MUS LD50:27 MG/KG CLDND*
? IHL-MUS LC50:32400 UG/M3 STGNBT -,173,1999
? IPR-MUS LD50:28 MG/KG JIHTAB 30,98,1948
? SCU-MUS LD50:23060 UG/KG MEPAAX 12,427,1961
? IVN-MUS LD50:19 MG/KG CLDND*
? UNR-MUS LD50:27 MG/KG BJCAAI 6,160,1952
? SKN-RBT LD50:20 MG/KG FMCHA2 -,C32,1991
? ORL-BWD LD50:23700 UG/KG AECTCV 12,355,1983
TARGET ORGAN DATA
? BRAIN AND COVERINGS (INCREASED INTRACRANIAL PRESSURE)
? PERIPHERAL NERVE AND SENSATION (SPASTIC PARALYSIS WITH/WITHOUT SENSORY CHANGE)
? SENSE ORGANS AND SPECIAL SENSES (MYDRIASIS, OTHER EYE EFFECTS)
? BEHAVIORAL (GENERAL ANESTHETIC, SOMNOLENCE, CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD,
CHANGE IN MOTOR ACTIVITY, COMA, HEADACHE, IRRITABILITY)
? CARDIAC (CARDIOMYOPATHY INCLUDING INFARCTION, ARRYTHMIAS, PULSE RATE INCREASED WITHOUT FALL
IN BP, PULSE RATE DECREASED WITH FALL IN BP, CHANGE IN FORCE OF CONTRACTION, OTHER CHANGES)
? VASCULAR (BP LOWERING NOT CHARACTERIZED IN AUTONOMIC SECTION)
? LUNGS, THORAX OR RESPIRATION (CHANGE IN TRACHEA OR BRONCHI, ACUTE PULMONARY EDEMA, DYSPNAE,
RESPIRATORY STIMULATION, OTHER CHANGES)
? GASTROINTESTINAL (HYPERMOTILITY, DIARRHEA)
? KIDNEY, URETER, BLADDER (OTHER CHANGES)
? BLOOD (CHANGES IN SPLEEN)
? MUSCULO-SKELETAL (OTHER CHANGES)
ONLY SELECTED REGISTRY OF TOXIC EFFECTS OF CHEMICAL SUBSTANCES (RTECS) DATA IS PRESENTED HERE.
SEE ACTUAL ENTRY IN RTECS FOR COMPLETE INFORMATION.
SECTION 12. - - - - - - - - - ECOLOGICAL INFORMATION - - - - - - - - - -
DATA NOT YET AVAILABLE.
SECTION 13. - - - - - - - - - DISPOSAL CONSIDERATIONS - - - - - - - - -
? CONTACT A LICENSED PROFESSIONAL WASTE DISPOSAL SERVICE TO DISPOSE OF THIS MATERIAL.
? OBSERVE ALL FEDERAL, STATE AND LOCAL ENVIRONMENTAL REGULATIONS.
SECTION 14. - - - - - - - - - - TRANSPORT INFORMATION - - - - - - - - -
CONTACT IMMUNO CONCEPTS N.A. LTD. FOR TRANSPORTATION INFORMATION.
SECTION 15. - - - - - - - - - REGULATORY INFORMATION - - - - - - - - - -
EUROPEAN INFORMATION
? EC INDEX NO: 011-004-00-7
? VERY TOXIC
? R 28 - VERY TOXIC IF SWALLOWED.
? R 32 - CONTACT WITH ACIDS LIBERATES VERY TOXIC GAS.
? R 50/53 - VERY TOXIC TO AQUATIC ORGANISMS, MAY CAUSE LONG-TERM ADVERSE EFFECTS IN THE AQUATIC
ENVIRONMENT.
? S 28 - AFTER CONTACT WITH SKIN, WASH IMMEDIATELY WITH PLENTY OF SOAPSUDS.
? S 45 - IN CASE OF ACCIDENT OR IF YOU FEEL UNWELL, SEEK MEDICAL ADVICE IMMEDIATELY (SHOW THE LABEL
WHERE POSSIBLE).
REVIEWS, STANDARDS, AND REGULATIONS
? OEL=MAK
? ACGIH TLV-NOT CLASSIFIABLE AS A HUMAN CARCINOGEN DTLVS* TLV/BEI,1999
? ACGIH TLV-CL 0.29 MG/M3 (SODIUM AZIDE) DTLVS* TLV/BEI,1999
? OEL-AUSTRALIA: TWA 0.1 PPM (0.3 MG/M3), JAN1993
? OEL-AUSTRIA: MAK 0.07 PPM (0.2 MG/M3), JAN1999
? OEL-BELGIUM: STEL 0.11 PPM (0.3 MG/M3), JAN1993
? OEL-DENMARK: TWA 0.3 MG/M3, JAN1999
? OEL-FINLAND: TWA 0.1 PPM (0.3 MG/M3), STEL 0.3 PPM (0.9 MG/M3), JAN1999
Document ID # 4.14.01.007.010 Revision # 2.0 Issue Date: 11/17/05 Page 4 of 28
? OEL-FRANCE: VLE 0.1 PPM (0.3 MG/M3), JAN1999
? OEL-GERMANY: MAK 0.07 PPM (0.2 MG/M3), JAN1999
? OEL-THE NETHERLANDS: MAC-TGG 0.1 PPM (0.3 MG/M3), JAN1999
? OEL-NORWAY: TWA 0.3 MG/M3, JAN1999
? OEL-SWITZERLAND: MAK-W 0.07 PPM (0.2 MG/M3), JAN1999
? OEL-UNITED KINGDOM: LTEL 0.1 PPM (0.3 MG/M3), STEL JAN1993
? OEL IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA CHECK ACGIH TLV;
? OEL IN NEW ZEALAND, SINGAPORE, VIETNAM CHECK ACGIH TLV
? NIOSH REL TO SODIUM AZIDE, AS HN3-AIR:CL 0.1 PPM (SK)
? NIOSH* DHHS #92-100,1992
? NOHS 1974: HZD 68820; NIS 13; TNF 877; NOS 10; TNE 5953
? NOES 1983: HZD 68820; NIS 19; TNF 3640; NOS 27; TNE 54959; TFE 38370
? EPA GENETOX PROGRAM 1988, POSITIVE: L5178Y CELLS IN VITRO-TK TEST
? EPA GENETOX PROGRAM 1988, POSITIVE: D MELANOGASTER SEX-LINKED LETHAL
? EPA GENETOX PROGRAM 1988, POSITIVE: S CEREVISIAE GENE CONVERSION
? EPA GENETOX PROGRAM 1988, POSITIVE: S CEREVISIAE-FORWARD MUTATION; S CEREVISIAE-REVERSION
? EPA GENETOX PROGRAM 1988, NEGATIVE: IN VITRO CYTOGENETICS-HUMAN LYMPHOCYTE
? EPA GENETOX PROGRAM 1988, NEGATIVE: SPERM MORPHOLOGY-MOUSE; IN VITRO UDS-HUMAN FIBROBLAST
? EPA GENETOX PROGRAM 1988, NEGATIVE: TRP REVERSION
? EPA GENETOX PROGRAM 1988, INCONCLUSIVE: CARCINOGENICITY-MOUSE/RAT; TRP REVERSION
? EPA TSCA SECTION 8(B) CHEMICAL INVENTORY
? EPA TSCA SECTION 8(D) UNPUBLISHED HEALTH/SAFETY STUDIES ON EPA IRIS DATABASE
? EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, OCTOBER 2000
? NIOSH CURRENT INTELLIGENCE BULLETIN 13, 1976
? NTP CARCINOGENESIS STUDIES (GAVAGE); NO EVIDENCE: RAT
? NTPTR* NTP-TR-389,1991
U.S. INFORMATION
? THIS PRODUCT IS SUBJECT TO SARA SECTION 313 REPORTING REQUIREMENTS.
SECTION 16. - - - - - - - - - - OTHER INFORMATION- - - - - - - - - - - -
THE ABOVE INFORMATION IS BELIEVED TO BE CORRECT BUT DOES NOT PURPORT TO BE ALL-INCLUSIVE AND
SHALL BE USED ONLY AS A GUIDE. IMMUNO CONCEPTS, N.A. LTD. SHALL NOT BE HELD LIABLE FOR ANY DAMAGE
RESULTING FROM HANDLING OR CONTACT WITH THE ABOVE PRODUCT.
COPYRIGHT 2005 IMMUNO CONCEPTS, N.A. LTD.
LICENSE GRANTED TO MAKE UNLIMITED PAPER COPIES FOR INTERNAL USE ONLY.
FICHE SIGNAL蒚IQUE DE S蒀URIT?(MSDS)
SECTION 1. - - - - - - - - - IDENTIFICATION DU PRODUIT- - - - - - - - - -
NOM ET
R蒄. CATALOGUE: CONJUGU蒘, CONTR訪ES ET DILUANTS DU SYST萂E DE TEST ANCA FLUORESCENT - S蒖IE
CATALOGUE: 10009, 10075, 10021, 10026, 10031, 10100.
CONJUGU蒘 ET CONTR訪ES DU SYST萂E DE TEST ANA FLUORESCENT - S蒖IE CATALOGUE:
2009, 2009-Ro, 2009G-Ro, 2075, 2075-Ro, 2075G-Ro, 2021, 2022, 2023, 2024, 2025, 2026, 2027, 2028,
2029, 2031, 2032, 2033, 2035, 2035-Ro, 2036, 2037, 2038, 2039, 2041.
CONJUGU蒘 ET CONTR訪ES DES SYST萂ES DE TEST ADNn FLUORESCENT - S蒖IE
CATALOGUE: 3009, 3009G, 3075, 3075G, 3021, 3026, 3031.
CONJUGU蒘 ET CONTR訪ES DES SYST萂ES DE TEST EBV-VCA, EBNA ET EA FLUORESCENT -
S蒖IE CATALOGUE: 9009, 9075, 9021, 9026, 9031.
LAMES ET R葾CTIFS DES SYST萂ES DE TEST D!AUTOANTICORPS AUTO ID?- S蒖IE
CATALOGUE: 7010, 6001, 6002, 6003, 6004, 6005, 6050, 6051, 7001, 7002, 7003.
CONTR訪ES ET CALIBRATEURS RELISA?- S蒖IE CATALOGUE: 7021, 7022, 7026, 7031, 7261,
7262, 7263, 7264, 7265
DISPOSITIF DE MONTAGE UNIVERSEL - S蒖IE CATALOGUE: 1111
CONTRE-COLORANT UNIVERSEL (BLEU D!EVANS 0,5 %) - S蒖IE CATALOGUE: 1105
DILUANT POUR S蒖UM - S蒖IE CATALOGUE: 100, 200, 500, 1000.
Document ID # 4.14.01.007.010 Revision # 2.0 Issue Date: 11/17/05 Page 5 of 28
Immuno Concepts, N.A. Ltd.
9779-D Business Park Drive
Sacramento, CA 95827 USA
Telephone: 916-363-2649
MATERIAL SAFETY DATA SHEET
SECTION 1. - - - - - - - - - CHEMICAL IDENTIFICATION- - - - - - - - - -
NAME: RELISA?SUBSTRATE SOUTION
CATALOG #: 7035
SECTION 2. - - - - - COMPOSITION/INFORMATION ON INGREDIENTS - - - - - -
PROPRIETARY MIXTURE. THE INFORMATION IN THIS DOCUMENT REFERS TO SUBSTANCES IN THE MIXTURE
PRESENT IN AMOUNTS GREATER THAN 1.0%, OR 0.1% IF THE SUBSTANCE IS CONSIDERED CARCINOGENIC.
SYNONYMS - NONE.
SECTION 3. - - - - - - - - - - HAZARDS IDENTIFICATION - - - - - - - - -
LABEL PRECAUTIONARY STATEMENTS
? IRRITANT
? FLAMMABLE
? TOXIC
? TOXIC BY INHALATION AND IF SWALLOWED. DO NOT BREATHE VAPOR.
? IRRITATING TO EYES AND SKIN. WEAR SUITABLE PROTECTIVE CLOTHING.
? READILY ABSORBED THROUGH THE SKIN. AVOID CONTACT WITH SKIN.
? RISK OF SERIOUS DAMAGE TO EYES. WEAR EYE/FACE PROTECTION.
? IN CASE OF CONTACT WITH EYES, RINSE IMMEDIATELY WITH PLENTY OF WATER AND SEEK MEDICAL
ADVICE.
? TARGET ORGAN(S): EYES, SKIN, LIVER, KIDNEYS
? KEEP CONTAINER TIGHTLY CLOSED.
? KEEP AWAY FROM SOURCES OF IGNITION - NO SMOKING.
? TAKE PRECAUTIONARY MEASURES AGAINST STATIC DISCHARGES.
? IN CASE OF ACCIDENT OR IF YOU FEEL UNWELL, SEEK MEDICAL ADVICE IMMEDIATELY.
SECTION 4. - - - - - - - - - - FIRST-AID MEASURES- - - - - - - - - - -
? IF SWALLOWED, WASH OUT MOUTH WITH WATER PROVIDED PERSON IS CONSCIOUS. CALL A PHYSICIAN
IMMEDIATELY.
? IF INHALED, REMOVE TO FRESH AIR. IF NOT BREATHING GIVE ARTIFICIAL RESPIRATION. IF BREATHING IS
DIFFICULT, GIVE OXYGEN.
? IN CASE OF SKIN CONTACT, FLUSH WITH COPIOUS AMOUNTS OF WATER FOR AT LEAST 15 MINUTES.
REMOVE CONTAMINATED CLOTHING AND SHOES. CALL A PHYSICIAN.
? IN CASE OF CONTACT WITH EYES, FLUSH WITH COPIOUS AMOUNTS OF WATER FOR AT LEAST 15
MINUTES. ASSURE ADEQUATE FLUSHING BY SEPARATING THE EYELIDS WITH FINGERS. CALL A
PHYSICIAN.
SECTION 5. - - - - - - - - - FIRE FIGHTING MEASURES - - - - - - - - - -
EXTINGUISHING MEDIA
? WATER SPRAY.
? CARBON DIOXIDE, DRY CHEMICAL POWDER OR APPROPRIATE FOAM.
SPECIAL FIREFIGHTING PROCEDURES
? WEAR SELF-CONTAINED BREATHING APPARATUS AND PROTECTIVE CLOTHING TO PREVENT CONTACT
WITH SKIN AND EYES.
Document ID # 4.14.01.007.011 Revision # 1.0 Issue Date: 10/31/03 Page 1 of 25
? UNUSUAL FIRE AND EXPLOSIONS HAZARDS
? FLAMMABLE LIQUID.
? EMITS TOXIC FUMES UNDER FIRE CONDITIONS.
? VAPOR MAY TRAVEL CONSIDERABLE DISTANCE TO SOURCE OF IGNITION AND FLASH BACK.
? CONTAINER EXPLOSION MAY OCCUR UNDER FIRE CONDITIONS.
? COMBUSTIBLE LIQUID.
? IT MAY UNDERGO A VIOLENT EXOTHERMIC REACTION ON MIXING WITH COPPER WOOL AND
TRICHLOROACETIC ACID. ON MIXING WITH POTASSIUM PERMANGANATE IT MAY FLASH
INSTANTANEOUSLY. IT MAY REACT VIOLENTLY WITH: ACID HALIDES, CYANURIC CHLORIDE, SILICON
TETRACHLORIDE, PHOSPHORUS TRICHLORIDE AND TRIOXIDE, THIONYL CHLORIDE, MAGNESIUM
PERCHLORATE, SILVER FLUORIDE, METHYL BROMIDE, IODINE PENTAFLUORIDE, NITROGEN PERIODATE,
DIBORANE, SODIUM HYDRIDE, PERCHLORIC AND PERIODIC ACIDS. WHEN HEATED ABOVE ITS BOILING
POINT IT MAY DEGRADE GIVING OFF FORMALDEHYDE, METHYL MERCAPTAN, AND SULFUR DIOXIDE.
SECTION 6. - - - - - - - - ACCIDENTAL RELEASE MEASURES- - - - - - - - -
? WEAR SELF-CONTAINED BREATHING APPARATUS, RUBBER BOOTS AND HEAVY RUBBER GLOVES.
? COVER WITH DRY-LIME, SAND, OR SODA ASH. PLACE IN COVERED CONTAINERS USING NON-SPARKING
TOOLS AND TRANSPORT OUTDOORS.
? VENTILATE AREA AND WASH SPILL SITE AFTER MATERIAL PICKUP IS COMPLETE.
? EVACUATE AREA.
? SHUT OFF ALL SOURCES OF IGNITION.
SECTION 7. - - - - - - - - - - HANDLING AND STORAGE- - - - - - - - - - -
REFER TO SECTION 8.
SECTION 8. - - - - - - EXPOSURE CONTROLS/PERSONAL PROTECTION- - - - - -
? SAFETY SHOWER AND EYE BATH.
? USE NONSPARKING TOOLS.
? AVOID CONTACT WITH EYES, SKIN AND CLOTHING.
? WASH CONTAMINATED CLOTHING PROMPTLY.
? WASH THOROUGHLY AFTER HANDLING.
? COMPATIBLE CHEMICAL-RESISTANT GLOVES.
? THE MATERIAL MAY SLOWLY PENETRATE PROTECTIVE GLOVES; THEREFORE IN CASE OF SPILLS,
DISCARD GLOVES AFTER USE.
? CHEMICAL SAFETY GOGGLES.
? KEEP CONTAINER CLOSED.
? KEEP AWAY FROM HEAT, SPARKS, AND OPEN FLAME.
? STORE REFRIGERATED.
? DO NOT BREATHE VAPOR.
? AVOID CONTACT WITH EYES, SKIN AND CLOTHING.
? AVOID PROLONGED OR REPEATED EXPOSURE.
? DO NOT USE IF SKIN IS CUT OR SCRATCHED. WASH THOROUGHLY AFTER HANDLING.
? HYGROSCOPIC
SECTION 9. - - - - - - - PHYSICAL AND CHEMICAL PROPERTIES - - - - - - -
APPEARANCE AND ODOR
? LIQUID MIXTURE.
PHYSICAL PROPERTIES
? THE PHYSICAL PROPERTIES OF THE MIXTURE HAVE NOT BEEN THOROUGHLY INVESTIGATED.
SECTION 10. - - - - - - - - -STABILITY AND REACTIVITY - - - - - - - - -
STABILITY
Document ID # 4.14.01.007.011 Revision # 1.0 Issue Date: 10/31/03 Page 2 of 25
? STABLE.
INCOMPATIBILITIES
? BASES.
? PROTECT FROM MOISTURE.
? ACIDS
? ACID CHLORIDES
? ACID ANHYDRIDES
? PHOSPHORUS HALIDES
? OXIDIZING AGENTS
? ALKALI METALS
? REDUCING AGENTS
HAZARDOUS COMBUSTION OR DECOMPOSITION PRODUCTS
? CARBON MONOXIDE, CARBON DIOXIDE
HAZARDOUS POLYMERIZATION
? WILL NOT OCCUR.
SECTION 11. - - - - - - - - - TOXICOLOGICAL INFORMATION - - - - - - - -
ACUTE EFFECTS
? CAUSES SKIN IRRITATION AND DERMATITIS.
? MAY BE HARMFUL IF ABSORBED THROUGH THE SKIN.
? READILY ABSORBED THROUGH THE SKIN.
? CAUSES EYE IRRITATION.
? TOXIC IF INHALED.
? MATERIAL IS IRRITATING TO MUCOUS MEMBRANES AND UPPER RESPIRATORY TRACT.
? TOXIC IF SWALLOWED.
? EXPOSURE CAN CAUSE:
GASTROINTESTINAL DISTURBANCES
MAY CAUSE CONVULSIONS.
? TO THE BEST OF OUR KNOWLEDGE, THE CHEMICAL, PHYSICAL, AND TOXICOLOGICAL PROPERTIES HAVE
NOT BEEN THOROUGHLY INVESTIGATED.
CHRONIC EFFECTS
TARGET ORGAN(S):
? EYES
? SKIN
? KIDNEYS
? LIVER
? HEART
IRRITATION DATA
? IRRITATION DATA OF MIXTURE HAS NOT BEEN THOROUGHLY INVESTIGATED.
TOXICITY DATA
? TOXICITY OF MIXTURE HAS NOT BEEN THOROUGHLY INVESTIGATED.
TARGET ORGAN DATA
? SENSE ORGANS AND SPECIAL SENSES (OPTIC NERVE NEUROPATHY, VISUAL FIELD CHANGES,
CONJUNCTIVA IRRITATION AND OTHER OLFACTION EFFECTS)
? BEHAVIORAL (HEADACHE, ALTERED SLEEP TIME, GENERAL ANESTHETIC, MUSCLE WEAKNESS AND
MUSCLE CONTRACTION OR SPASTICITY)
Document ID # 4.14.01.007.011 Revision # 1.0 Issue Date: 10/31/03 Page 3 of 25
? LUNGS, THORAX OR RESPIRATION (DYSPNAE, CYANOSIS, RESPIRATORY DEPRESSION AND OTHER
CHANGES)
? GASTROINTESTINAL (NAUSEA OR VOMITING)
? KIDNEY, URETER, BLADDER (RENAL FUNCTION TESTS DEPRESSED)
? LIVER (JAUNDICE, OTHER OR UNCLASSIFIED)
? BLOOD (OTHER CHANGES)
? EFFECTS ON FERTILITY (PRE-IMPLANTATION MORTALITY, POST-IMPLANTATION MORTALITY)
? EFFECTS ON EMBRYO OR FETUS (FETOTOXICITY)
? SPECIFIC DEVELOPMENTAL ABNORMALITIES (CENTRAL NERVOUS SYSTEM AND MUSCULOSKELETAL
SYSTEM)
? ONLY SELECTED REGISTRY OF TOXIC EFFECTS OF SUBSTANCES CONTAINED IN THE MIXTURE IN
AMOUNTS GREATER THAN 1% IS PRESENTED HERE. THE MIXTURE HAS NOT BEEN THOROUGHLY
INVESTIGATED.
SECTION 12. - - - - - - - - - ECOLOGICAL INFORMATION - - - - - - - - - -
DATA NOT YET AVAILABLE.
SECTION 13. - - - - - - - - - DISPOSAL CONSIDERATIONS - - - - - - - - -
? CONTACT A LICENSED PROFESSIONAL WASTE DISPOSL SERVICE TO DISPOSE OF THIS MATERIAL OR
BURN IN A CHEMICAL INCINERATOR EQUIPPED WITH AN AFTERBURNER AND SCRUBBER.
? OBSERVE ALL FEDERAL, STATE AND LOCAL ENVIRONMENTAL REGULATIONS.
SECTION 14. - - - - - - - - - - TRANSPORT INFORMATION - - - - - - - - -
CONTACT IMMUNO CONCEPTS N.A. LTD. FOR TRANSPORTATION INFORMATION.
SECTION 15. - - - - - - - - - REGULATORY INFORMATION - - - - - - - - - -
EUROPEAN INFORMATION
? PROPRIETARY MIXTURE.
? HIGHLY FLAMMABLE
? TOXIC
? IRRITANT
? R 11 ?HIGHLY FLAMMABLE
? R 36/37/38 ?IRRITATING TO EYES, RESPIRATORY SYSTEM AND SKIN.
? R 66 ?REPEATED EXPOSURE MAY CAUSE SKIN DRYNESS OR CRACKING.
? R 67 ?VAPORS MAY CAUSE DROWSINESS AND DIZZINESS.
? S 7 ?KEEP CONTAINER TIGHTLY CLOSED.
? S 9 ?KEEP CONTAINER IN A WELL-VENTILATED PLACE.
? S 16 ?KEEP AWAY FROM SOURCES OF IGNITION ?NO SMOKING.
? S 23/25 ?DO NOT BREATHE VAPOR. TOXIC BY INHALATION AND IF SWALLOWED.
? S 24 ?AVOID CONTACT WITH SKIN.
? S 26 ?IN CASE OF CONTACT WITH EYES, RINSE IMMEDIATELY WITH PLENTY OF WATER AND SEEK
MEDICAL ADVICE.
? S 36 ?WEAR SUITABLE PROTECTIVE CLOTHING.
? S 45 ?IN CASE OF ACCIDENT OR IF YOU FEEL UNWELL, SEEK MEDICAL ADVICE IMMEDIATELY.
REVIEWS, STANDARDS, AND REGULATIONS
? NOT AVAILABLE FOR PROPRIETARY MIXTURE.
SECTION 16. - - - - - - - - - - OTHER INFORMATION- - - - - - - - - - - -
THE ABOVE INFORMATION IS BELIEVED TO BE CORRECT BUT DOES NOT PURPORT TO BE ALL-INCLUSIVE AND
SHALL BE USED ONLY AS A GUIDE. IMMUNO CONCEPTS, N.A. LTD. SHALL NOT BE HELD LIABLE FOR ANY DAMAGE
RESULTING FROM HANDLING OR CONTACT WITH THE ABOVE PRODUCT.
Document ID # 4.14.01.007.011 Revision # 1.0 Issue Date: 10/31/03 Page 4 of 25
COPYRIGHT 2003 IMMUNO CONCEPTS, N.A. LTD.
LICENSE GRANTED TO MAKE UNLIMITED PAPER COPIES FOR INTERNAL USE ONLY.
FICHE SIGNAL蒚IQUE DE S蒀URIT?br>
SECTION 1. - - - - - - - - - IDENTIFICATION CHIMIQUE- - - - - - - - - -
NOM : SOLUTION DE SUBSTRAT RELISA?br>
R蒄. CATALOGUE : 7035
SECTION 2. - - - - - COMPOSITION/INFORMATIONS RELATIVES AUX INGR蒁IENTS - - - - - -
M蒐ANGE PROPRI蒚AIRE. LES INFORMATIONS COMMUNIQU蒃S DANS CE DOCUMENT FONT R蒄蒖ENCE AUX
SUBSTANCES DU M蒐ANGE PR蒘ENTES EN QUANTIT蒘 SUP蒖IEURES ?1,0 %, OU 0,1 % SI LA SUBSTANCE EST
CONSID蒖蒃 COMME CANC蒖OG萅E.
SYNONYMES - AUCUN.
SECTION 3. - - - - - - - - - - IDENTIFICATION DES RISQUES - - - - - - - - -
MISE EN GARDE FIGURANT SUR L!蒚IQUETTE
? IRRITANT
? INFLAMMABLE
? TOXIQUE
? TOXIQUE PAR INHALATION OU EN CAS D!INGESTION. NE PAS INHALER LA VAPEUR.
? IRRITANT POUR LES YEUX ET LA PEAU. PORTER UN V蔜EMENT DE PROTECTION APPROPRI?
? ABSORB?RAPIDEMENT PAR LA PEAU. 蒝ITER LE CONTACT AVEC LA PEAU.
? RISQUE DE L蒘IONS OCULAIRES GRAVES. PORTER UN APPAREIL DE PROTECTION DES YEUX/DU VISAGE.
? EN CAS DE CONTACT AVEC LES YEUX, LAVER IMM蒁IATEMENT ET ABONDAMMENT AVEC DE L!EAU ET
CONSULTER UN SP蒀IALISTE.
? ORGANES CIBLES : YEUX, PEAU, FOIE, REINS
? CONSERVER LE R蒀IPIENT BIEN FERM?
? CONSERVER ?L'蒀ART DE TOUTE FLAMME OU SOURCE D'蒚INCELLES ?NE PAS FUMER.
? 蒝ITER L'ACCUMULATION DE CHARGES 蒐ECTROSTATIQUES.
? EN CAS D!ACCIDENT OU DE MALAISE, CONSULTER IMM蒁IATEMENT UN M蒁ECIN.
SECTION 4. - - - - - - - - - - PREMIERS SOINS- - - - - - - - - - -
? EN CAS D!INGESTION, RINCER LA BOUCHE AVEC DE L!EAU (SEULEMENT SI LA PERSONNE EST
CONSCIENTE). APPELER IMM蒁IATEMENT UN M蒁ECIN.
? EN CAS D!INHALATION, TRANSPORTER LA VICTIME HORS DE LA ZONE CONTAMIN蒃. SI LA PERSONNE NE
RESPIRE PAS, PRATIQUER LA VENTILATION ARTIFICIELLE. SI LA PERSONNE RESPIRE DIFFICILEMENT, LA
PLACER SOUS OXYG萅E.
? EN CAS DE CONTACT CUTAN? SE LAVER ABONDAMMENT AVEC DE L'EAU PENDANT AU MOINS
15 MINUTES. RETIRER LES V蔜EMENTS ET LES CHAUSSURES CONTAMIN蒘. APPELER UN M蒁ECIN.
? EN CAS DE CONTACT AVEC LES YEUX, LAVER ABONDAMMENT AVEC DE L!EAU PENDANT AU MOINS
15 MINUTES. VEILLER ?PROC蒁ER ?UN RIN茿GE CORRECT EN 蒀ARTANT LES PAUPI萊ES AVEC LES
DOIGTS. APPELER UN M蒁ECIN.
SECTION 5. - - - - - - - - - LUTTE CONTRE L!INCENDIE - - - - - - - - - -
DISPOSITIFS D!EXTINCTION
? PULV蒖ISATION D!EAU.
? DIOXYDE DE CARBONE, POUDRE CHIMIQUE S菴HE OU MOUSSE APPROPRI蒃.
PROC蒁URES SP蒀IALES DE LUTTE CONTRE L!INCENDIE
? PORTER UN APPAREIL RESPIRATOIRE AUTONOME ET DES V蔜EMENTS DE PROTECTION AFIN D!蒝ITER
LE CONTACT AVEC LA PEAU ET LES YEUX.
Document ID # 4.14.01.007.011 Revision # 1.0 Issue Date: 10/31/03 Page 5 of 25
Immuno Concepts, N.A. Ltd.
9779-D Business Park Drive
Sacramento, CA 95827 USA
Telephone: 916-363-2649
November 14, 2007
MATERIAL SAFETY DATA SHEET (MSDS)
SECTION 1. - - - - - - - - - CHEMICAL IDENTIFICATION- - - - - - - - - -
NAME: RELISA?STOPPING SOLUTION
CATALOG #: 7033
SECTION 2. - - - - - COMPOSITION/INFORMATION ON INGREDIENTS - - - - - -
PROPRIETARY MIXTURE. THE INFORMATION IN THIS DOCUMENT REFERS TO SUBSTANCES IN THE MIXTURE
PRESENT IN AMOUNTS GREATER THAN 1.0%, OR 0.1% IF THE SUBSTANCE IS CONSIDERED CARCINOGENIC.
SYNONYMS - NONE.
SECTION 3. - - - - - - - - - - HAZARDS IDENTIFICATION - - - - - - - -
LABEL PRECAUTIONARY STATEMENTS
? HIGHLY TOXIC (USA)
? TOXIC (EU)
? MAY CAUSE CANCER BY INHALATION.
? TOXIC BY INHALATION. DO NOT BREATHE VAPOR.
? HARMFUL IN CONTACT WITH SKIN AND IF SWALLOWED.
? CAUSES BURNS.
? CORROSIVE
? REACTS VIOLENTLY WITH WATER.
? TARGET ORGAN(S): TEETH, CARDIOVASCULAR SYSTEM
? IN CASE OF CONTACT WITH EYES, RINSE IMMEDIATELY WITH PLENTY OF WATER AND SEEK MEDICAL
ADVICE.
? IN CASE OF ACCIDENT OR IF YOU FEEL UNWELL, SEEK MEDICAL ADVICE IMMEDIATELY.
? TAKE OFF ALL CONTAMINATED CLOTHING IMMEDIATELY.
? WEAR SUITABLE PROTECTIVE CLOTHING, GLOVES AND EYE/FACE PROTECTION.
SECTION 4. - - - - - - - - - - FIRST-AID MEASURES- - - - - - - - - - -
? IF SWALLOWED, WASH OUT MOUTH WITH WATER PROVIDED PERSON IS CONSCIOUS. CALL A
PHYSICIAN IMMEDIATELY.
? IF INHALED, REMOVE TO FRESH AIR. IF NOT BREATHING GIVE ARTIFICIAL RESPIRATION. IF BREATHING
IS DIFFICULT, GIVE OXYGEN.
? IN CASE OF SKIN CONTACT, FLUSH WITH COPIOUS AMOUNTS OF WATER FOR AT LEAST 15 MINUTES.
REMOVE CONTAMINATED CLOTHING AND SHOES. CALL A PHYSICIAN.
? IN CASE OF CONTACT WITH EYES, FLUSH WITH COPIOUS AMOUNTS OF WATER FOR AT LEAST 15
MINUTES. ASSURE ADEQUATE FLUSHING BY SEPARATING THE EYELIDS WITH FINGERS. CALL A
PHYSICIAN.
SECTION 5. - - - - - - - - - FIRE FIGHTING MEASURES - - - - - - - - - -
EXTINGUISHING MEDIA
? CARBON DIOXIDE, DRY CHEMICAL POWDER OR APPROPRIATE FOAM.
? DO NOT USE WATER.
SPECIAL FIREFIGHTING PROCEDURES.
? WEAR SELF-CONTAINED BREATHING APPARATUS AND PROTECTIVE CLOTHING TO PREVENT CONTACT
WITH SKIN AND EYES.
Document ID # 4.14.01.007.012 Revision # 2.0 Issue Date: 11/14/07 Page 1 of 19
UNUSUAL FIRE AND EXPLOSIONS HAZARDS.
? EMITS TOXIC FUMES UNDER FIRE CONDITIONS.
SECTION 6. - - - - - - - - ACCIDENTAL RELEASE MEASURES- - - - - - - - -
? WEAR SELF-CONTAINED BREATHING APPARATUS, RUBBER BOOTS AND HEAVY RUBBER GLOVES.
? COVER WITH DRY-LIME, SAND, OR SODA ASH. PLACE IN COVERED CONTAINERS USING NON-SPARKING
TOOLS AND TRANSPORT OUTDOORS.
? VENTILATE AREA AND WASH SPILL SITE AFTER MATERIAL PICKUP IS COMPLETE.
? EVACUATE AREA.
SECTION 7. - - - - - - - - - - HANDLING AND STORAGE- - - - - - - - - - -
REFER TO SECTION 8.
SECTION 8. - - - - - - EXPOSURE CONTROLS/PERSONAL PROTECTION- - - - - -
? WASH CONTAMINATED CLOTHING BEFORE REUSE.
? WASH THOROUGHLY AFTER HANDLING.
? DO NOT BREATHE VAPOR.
? DO NOT GET IN EYES, ON SKIN, ON CLOTHING.
? AVOID PROLONGED OR REPEATED EXPOSURE.
? COMPATIBLE CHEMICAL-RESISTANT GLOVES.
? CHEMICAL SAFETY GOGGLES.
? FACESHIELD (8-INCH MINIMUM).
? SAFETY SHOWER AND EYE BATH.
? USE ONLY IN A CHEMICAL FUME HOOD.
? KEEP TIGHTLY CLOSED.
? STORE IN A COOL DRY PLACE.
? DO NOT ALLOW CONTACT WITH WATER.
SECTION 9. - - - - - - - PHYSICAL AND CHEMICAL PROPERTIES - - - - - - -
APPEARANCE AND ODOR: LIQUID MIXTURE.
SECTION 10. - - - - - - - - -STABILITY AND REACTIVITY - - - - - - - - -
STABILITY
? STABLE.
INCOMPATIBILITIES
? PROTECT FROM MOISTURE.
? DO NOT ALLOW WATER TO ENTER CONTAINER.
? BASES
? AMINES
? ALKALI METALS
? COPPER, COPPER ALLOYS
? ALUMINUM
? HALIDES
? ORGANIC MATERIALS
? FINELY POWDERED METALS
? INCOMPATIBLE WITH CARBIDES, CHLORATES, FULMINATES, NITRATES, PICRATES, CYANIDES, ALKALI
HALIDES, ZINC IODIDE, PERMANGANATES, HYDROGEN PEROXIDE, AZIDES, PERCHLORATES,
NITROMETHANE, PHOSPHOROUS, NITRITES. MAY HAVE A VIOLENT REACTION WITH:
CYCLOPENTADIENE, CYCLOPENTANONE OXIME, NITROARYL AMINES, HEXALITHIUM DISILICIDE,
PHOSPHOROUS (III) OXIDE.
HAZARDOUS COMBUSTION OR DECOMPOSITION PRODUCTS
? HYDROGEN CHLORIDE GAS
Document ID # 4.14.01.007.012 Revision # 2.0 Issue Date: 11/14/07 Page 2 of 19
HAZARDOUS POLYMERIZATION
? WILL NOT OCCUR.
SECTION 11. - - - - - - - - - TOXICOLOGICAL INFORMATION - - - - - - - -
ACUTE EFFECTS
? MATERIAL IS EXTREMELY DESTRUCTIVE TO TISSUE OF THE MUCOUS MEMBRANES AND UPPER
RESPIRATORY TRACT, EYES AND SKIN.
? INHALATION MAY RESULT IN SPASM, INFLAMMATION AND EDEMA OF THE LARYNX AND BRONCHI,
CHEMICAL PNEUMONITIS AND PULMONARY EDEMA.
? SYMPTOMS OF EXPOSURE MAY INCLUDE BURNING SENSATION, COUGHING, WHEEZING, LARYNGITIS,
SHORTNESS OF BREATH, HEADACHE, NAUSEA AND VOMITING.
? CAUSES BURNS.
? MAY BE FATAL IF INHALED, SWALLOWED, OR ABSORBED THROUGH THE SKIN.
CHRONIC EFFECTS
TARGET ORGAN(S):
? TEETH
? CARDIOVASCULAR SYSTEM
IRRITATION DATA
? IRRITATION DATA OF MIXTURE HAS NOT BEEN THOROUGHLY INVESTIGATED.
TOXICITY DATA
? TOXICITY OF MIXTURE HAS NOT BEEN THOROUGHLY INVESTIGATED.
TARGET ORGAN DATA
? SENSE ORGANS AND SPECIAL SENSES (OTHER EYE EFFECTS)
? VASCULAR (BP LOWERING NOT CHARACTERIZED IN AUTONOMIC SECTION)
? LUNGS, THORAX OR RESPIRATION (RESPIRATORY DEPRESSION OR STIMULATION)
? GASTROINTESTINAL (CHANGES IN STRUCTURE OR FUNCTION OF ESOPHAGUS)
? SKIN AND APPENDAGES (AFTER SYSTEMIC EXPOSURE: DERMATITIS, OTHER)
SECTION 12. - - - - - - - - - ECOLOGICAL INFORMATION - - - - - - - - - -
DATA NOT YET AVAILABLE.
SECTION 13. - - - - - - - - - DISPOSAL CONSIDERATIONS - - - - - - - - -
CONTACT A LICENSED PROFESSIONAL WASTE DISPOSAL SERVICE TO DISPOSE OF THIS
MATERIAL.OBSERVE ALL FEDERAL, STATE AND LOCAL ENVIRONMENTAL REGULATIONS.
SECTION 14. - - - - - - - - - - TRANSPORT INFORMATION - - - - - - - - -
CONTACT IMMUNO CONCEPTS N.A. LTD. FOR TRANSPORTATION INFORMATION.
SECTION 15. - - - - - - - - - REGULATORY INFORMATION - - - - - - - - - -
EUROPEAN INFORMATION
? PROPRIETARY MIXTURE.
? TOXIC
? CORROSIVE
? R 23 ?TOXIC BY INHALATION.
? R 35 - CAUSES SEVERE BURNS.
? S 9 ?KEEP CONTAINER IN A WELL-VENTILATED PLACE.
? S 26 - IN CASE OF CONTACT WITH EYES, RINSE IMMEDIATELY WITH PLENTY OF WATER AND SEEK
MEDICAL ADVICE.
? S 30 - NEVER ADD WATER TO THIS PRODUCT.
? S 36/37/39 ?WEAR SUITABLE PROTECTIVE CLOTHING, GLOVES AND EYE/FACE PROTECTION.
? S 45 - IN CASE OF ACCIDENT OR IF YOU FEEL UNWELL, SEEK MEDICAL ADVICE IMMEDIATELY.
Document ID # 4.14.01.007.012 Revision # 2.0 Issue Date: 11/14/07 Page 3 of 19
REVIEWS, STANDARDS, AND REGULATIONS
? NOT AVAILABLE FOR PROPRIETARY MIXTURE.
SECTION 16. - - - - - - - - - - OTHER INFORMATION- - - - - - - - - - - -
THE ABOVE INFORMATION IS BELIEVED TO BE CORRECT BUT DOES NOT PURPORT TO BE ALL-INCLUSIVE
AND SHALL BE USED ONLY AS A GUIDE. IMMUNO CONCEPTS, N.A. LTD. SHALL NOT BE HELD LIABLE FOR
ANY DAMAGE RESULTING FROM HANDLING OR CONTACT WITH THE ABOVE PRODUCT.
COPYRIGHT 2001 IMMUNO CONCEPTS, N.A. LTD.LICENSE GRANTED TO MAKE UNLIMITED PAPER COPIES
FOR INTERNAL USE ONLY.
FICHE SIGNAL蒚IQUE DE S蒀URIT?(MSDS)
SECTION 1. - - - - - - - - - IDENTIFICATION CHIMIQUE- - - - - - - - - -
NOM: SOLUTION D!ARR蔜 RELISA?br>
R蒄. CATALOGUE: 7033
SECTION 2. - - - - - COMPOSITION/INFORMATIONS RELATIVES AUX INGR蒁IENTS - - - - - -
M蒐ANGE PROPRI蒚AIRE. LES INFORMATIONS COMMUNIQU蒃S DANS CE DOCUMENT FONT R蒄蒖ENCE
AUX SUBSTANCES DU M蒐ANGE PR蒘ENTES EN QUANTIT蒘 SUP蒖IEURES ?1,0 %, OU ?0,1 % SI LA
SUBSTANCE EST CONSID蒖蒃 COMME 蒚ANT CANC蒖OG萅E.SYNONYMES - AUCUN.
SECTION 3. - - - - - - - - - - IDENTIFICATION DES RISQUES - - - - - - - - -
MISE EN GARDE FIGURANT SUR L!蒚IQUETTE
? EXTR蔒EMENT TOXIQUE (?-U.)
? TOXIQUE (UE)
? PEUT CAUSER LE CANCER PAR INHALATION.
? TOXIQUE PAR INHALATION. NE PAS INHALER LA VAPEUR.
? DANGER EN CAS DE CONTAC T AVEC LA PEAU ET D!INGESTION.
? PROVOQUE DES BR跮URES.
? CORROSIF
? R葾GIT VIOLEMMENT AU CONTACT DE L!EAU.
ORGANES CIBLES : DENTS, SYST萂E CARDIOVASCULAIRE
?br>
? EN CAS DE CONTACT AVEC LES YEUX, LAVER IMM蒁IATEMENT ET ABONDAMMENT AVEC DE L'EAU ET
CONSULTER UN SP蒀IALISTE.
? EN CAS D!ACCIDENT OU DE MALAISE, CONSULTER IMM蒁IATEMENT UN M蒁ECIN.
? RETIRER IMM蒁IATEMENT TOUS LES V蔜EMENTS CONTAMIN蒘.
? PORTER DES V蔜EMENTS DE PROTECTION APPROPRI? DES GANTS ET UN APPAREIL DE PROTECTION
DES YEUX/DU VISAGE.
SECTION 4. - - - - - - - - - - PREMIERS SOINS - - - - - - - - - - -
? EN CAS D!INGESTION, RINCER LA BOUCHE AVEC DE L!EAU (SEULEMENT SI LA PERSONNE EST
CONSCIENTE). APPELER IMM蒁IATEMENT UN M蒁ECIN.
? EN CAS D!INHALATION, TRANSPORTER LA VICTIME HORS DE LA ZONE CONTAMIN蒃. SI LA PERSONNE
NE RESPIRE PAS, PRATIQUER LA VENTILATION ARTIFICIELLE. SI LA PERSONNE RESPIRE
DIFFICILEMENT, LA PLACER SOUS OXYG萅E.
? EN CAS DE CONTACT CUTAN? SE LAVER ABONDAMMENT AVEC DE L'EAU PENDANT AU MOINS 15
MINUTES. RETIRER LES V蔜EMENTS ET LES CHAUSSURES CONTAMIN蒘. APPELER UN M蒁ECIN.
? EN CAS DE CONTACT AVEC LES YEUX, LAVER ABONDAMMENT PENDANT AU MOINS 15 MINUTES.
VEILLER ?PROC蒁ER ?UN RIN茿GE CORRECT EN 蒀ARTANT LES PAUPI萊ES AVEC LES DOIGTS.
APPELER UN M蒁ECIN.
SECTION 5. - - - - - - - - - LUTTE CONTRE L!INCENDIE - - - - - - - - - -
Document ID # 4.14.01.007.012 Revision # 2.0 Issue Date: 11/14/07 Page 4 of 19
Immuno Concepts, N.A. Ltd.
9779-D Business Park Drive
Sacramento, CA 95827 USA
Telephone: 916-363-2649
October 31, 2003
CERTIFICATE OF ORIGIN
THIS IS TO CERTIFY THAT IMMUNO CONCEPTS, N.A.LTD. PRODUCTS FOR IN VITRO DIAGNOSTIC AND/OR
RESEARCH USE DO NOT CONTAIN, AND ARE NOT DERIVED FROM, SPECIFIED RISK MATERIAL AS DEFINED IN
COMMISSION DECISION 97/534/EC:
"The Directive prohibits the use of specified risk material defined as brain and eyes, tonsils and spinal cord of bovine animals,
ovine and caprine animals of over 1 year age or the spleens of ovine and caprine animals, in food. It also prohibits the use of
Vertebral columns of bovine, ovine and caprine animals in food."
PRODUCTS OF BOVINE, OVINE AND/OR CAPRINE ORIGIN USED IN THE MANUFACTURE OF IMMUNO CONCEPTS!
PRODUCTS ARE DERIVED FROM ANIMALS BORN AND RAISED IN THE UNITED STATES OF AMERICA OR CANADA
AND DO NOT CONTAIN ANY HAZARDOUS MATERIALS.
I HEREBY CERTIFY THAT AT THE ORIGIN OF THE SHIPMENTS AND WITHIN A RADIUS OF 25KM, THERE HAS BEEN
NO ANIMAL EPIDEMIC DURING THE TIME OF MANUFACTURING OR DISPATCH, UNDER THE OIE LIST A, NOR HAS
THERE BEEN ANY REPORTED DISEASE IN THE LAST 24 MONTHS FROM WHICH THE PRODUCTS AND PRODUCT
COMPONENTS ARE OBTAINED AND REPORTED.
CERTIFICAT D!ORIGINE
LE PR蒘ENT DOCUMENT CERTIFIE QUE LES PRODUITS D!IMMUNO CONCEPTS, N.A. LTD. DESTIN蒘 AU
DIAGNOSTIC IN VITRO ET/OU ?LA RECHERCHE NE CONTIENNENT PAS ET NE PROVIENNENT PAS DE MAT蒖IELS
COMPORTANT UN RISQUE SP蒀IFIQUE TEL QUE D蒄INI DANS LA D蒀ISION 97/534/CE DE LA COMMISSION :
?La Directive interdit l!utilisation, dans la nourriture, de mat閞iels ?risque sp閏ifique d閒inis comme 閠ant le cerveau et les
yeux, les amygdales et la moelle 閜ini鑢e des bovins, ovins et caprins 鈍閟 de plus d!un an ou les rates des ovins et des
caprins. Elle interdit 間alement l!utilisation dans la nourriture des colonnes vert閎rales des bovins, ovins et caprins. ?br>
LES PRODUITS D!ORIGINE BOVINE, OVINE ET/OU CAPRINE UTILIS蒘 DANS LA FABRICATION DES PRODUITS
D!IMMUNO CONCEPTS PROVIENNENT D!ANIMAUX N蒘 ET 蒐EV蒘 AUX 蒚ATS-UNIS OU AU CANADA ET NE
CONTIENNENT AUCUN MAT蒖IEL DANGEREUX.
JE CERTIFIE PAR LE PR蒘ENT DOCUMENT QUE, SUR LE LIEU D!EXP蒁ITION ET DANS UN RAYON DE 25 KM, IL N!Y
AVAIT PAS D!ANIMAUX CONTAGIEUX AU MOMENT DE LA FABRICATION OU DE L!EXP蒁ITION, CONFORM蒑ENT ?br>
LA LISTE A DE L!OFFICE INTERNATIONAL DES 蒔IZOOTIES, ET QU!AUCUNE MALADIE N!A 蒚?RAPPORT蒃 AU
COURS DES 24 DERNIERS MOIS PENDANT LESQUELS LES PRODUITS ET COMPOSANTS DU PRODUIT ONT 蒚?br>
OBTENUS ET ONT FAIT L'OBJET D'UN RAPPORT.
Document ID # 4.14.01.007.013 Revision # 1.0 Issue Date: 10/31/03 Page 1 of 3
|